DoW, Ovarian Cancer, Pilot Award
DOD-AMRAA Posted HT942526OCRPPA
Close Date:
October 1, 2026
60 days remaining
Description
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- $4,550,000.00
- Expected Awards
- 13
Key Dates
- Posted
- May 4, 2026
- Closes
- October 1, 2026 60d
- Archive Date
- October 31, 2026
Agency Information
- Agency Name
- Defense Health Agency Contracting Activity - DHACA
- Agency Code
- DOD-AMRAA
- Funding Instrument
- Other